Latest news
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBCCNBC · Thu, 06 Aug 2026 13:45:29 GMTBank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says - CNBCCNBC · Wed, 05 Aug 2026 14:34:07 GMTEli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge - CNBCCNBC · Wed, 05 Aug 2026 10:45:42 GMTNovo Nordisk CEO addresses investors' high Wegovy pill expectations - CNBCCNBC · Wed, 05 Aug 2026 08:27:00 GMTCNBC Daily Open: Markets rally on hopes of Iran-U.S. Strait of Hormuz deal - CNBCCNBC · Wed, 05 Aug 2026 06:46:20 GMTNovo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5% - CNBCCNBC · Wed, 05 Aug 2026 06:11:31 GMTPortal Innovations CEO John Flavin: Novo Nordisk is undervalued - CNBCCNBC · Tue, 04 Aug 2026 21:57:00 GMTNovo Nordisk shares slide after guidance disappoints investors - CNBCCNBC · Tue, 04 Aug 2026 17:30:15 GMT